Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA User Fee Hearing Hijacked By US Health Care Reform Arguments

Mar 22 2017

• By Derrick Gingery

Capitol House

Related Content

GPhA Pushes REMS Pay-for, Schedule III Hydrocodone In User Fee Bill

Jun 07 2012

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

REMS Reform Seems Distant Goal For Generics After Limited Support At US House Hearing

Mar 03 2017

Bill To Speed ANDA Approvals Gets Cool Reception From Industry, US FDA

Mar 03 2017

US Generic Reviews: Would Pre-Submission Meetings Be Better Than Six-Month Priority Review?

Mar 06 2017

Additional Topics

United States Generic Drugs Pricing Debate Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window